Log in to save to my catalogue

Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myoca...

Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myoca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1559008844

Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: A meta-analysis of individual patient data

About this item

Full title

Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: A meta-analysis of individual patient data

Publisher

United States: Elsevier Inc

Journal title

The American heart journal, 2014-09, Vol.168 (3), p.354-362.e2

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Background Erythropoiesis-stimulating agents (ESAs) have been investigated in small studies in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Erythropoiesis-stimulating agents did not show a clear effect on left ventricular function or clinical outcome, but some studies suggeste...

Alternative Titles

Full title

Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: A meta-analysis of individual patient data

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1559008844

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1559008844

Other Identifiers

ISSN

0002-8703

E-ISSN

1097-6744

DOI

10.1016/j.ahj.2014.04.020

How to access this item